M H Weinberger

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. ncbi Effects of eplerenone versus losartan in patients with low-renin hypertension
    Myron H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis, IN 46202 5111, USA
    Am Heart J 150:426-33. 2005
  2. ncbi Sodium and blood pressure 2003
    Myron H Weinberger
    Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA
    Curr Opin Cardiol 19:353-6. 2004
  3. ncbi The use of selective aldosterone antagonists
    Myron H Weinberger
    Indiana University Medical Center, 541 Clinical Drive, Room 423, Indianapolis, IN 46202, USA
    Curr Hypertens Rep 6:342-5. 2004
  4. ncbi Eplerenone: a new selective aldosterone receptor antagonist
    Myron H Weinberger
    Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Drugs Today (Barc) 40:481-5. 2004
  5. ncbi More on the sodium saga
    Myron H Weinberger
    Indiana University School of Medicine, 541 Clinical Building, Room 423, Indianapolis, IN 46202, USA
    Hypertension 44:609-11. 2004
  6. ncbi The use of aldosterone receptor blockers in the treatment of hypertension
    Myron H Weinberger
    Indiana University School of Medicine, 541 Clinical Drive, Room 423, Indianapolis, IN 46202, USA
    J Clin Hypertens (Greenwich) 6:632-5. 2004
  7. ncbi Is salt sensitivity of blood pressure linked to the cardiometabolic syndrome?
    Myron H Weinberger
    Department of Medicine Hypertension, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Cardiometab Syndr 1:217-9. 2006
  8. ncbi Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases
    M H Weinberger
    Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA
    Kidney Int 70:2051-3. 2006
  9. ncbi Is primary aldosteronism a benign disorder? Old evidence reconfirmed
    Myron H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Am J Hypertens 19:628. 2006
  10. ncbi Pathogenesis of salt sensitivity of blood pressure
    Myron H Weinberger
    Indiana University Medical Center, 541 Clinical Drive, Room 423, Indianapolis, IN 46202, USA
    Curr Hypertens Rep 8:166-70. 2006

Collaborators

Detail Information

Publications35

  1. ncbi Effects of eplerenone versus losartan in patients with low-renin hypertension
    Myron H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis, IN 46202 5111, USA
    Am Heart J 150:426-33. 2005
    ..Agents that block aldosterone at its receptor sites, therefore, should have significant clinical benefit in patients with low-renin hypertension...
  2. ncbi Sodium and blood pressure 2003
    Myron H Weinberger
    Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA
    Curr Opin Cardiol 19:353-6. 2004
    ..In view of the ongoing controversy about the importance of dietary sodium intake in blood pressure control, consideration of the most recent findings in this area is useful...
  3. ncbi The use of selective aldosterone antagonists
    Myron H Weinberger
    Indiana University Medical Center, 541 Clinical Drive, Room 423, Indianapolis, IN 46202, USA
    Curr Hypertens Rep 6:342-5. 2004
    ..The major findings with this new agent are presented herein...
  4. ncbi Eplerenone: a new selective aldosterone receptor antagonist
    Myron H Weinberger
    Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Drugs Today (Barc) 40:481-5. 2004
    ..This agent appears to be a promising and effective new addition for the treatment of hypertension and heart failure with few of the side-effects that have plagued earlier drugs of this class...
  5. ncbi More on the sodium saga
    Myron H Weinberger
    Indiana University School of Medicine, 541 Clinical Building, Room 423, Indianapolis, IN 46202, USA
    Hypertension 44:609-11. 2004
  6. ncbi The use of aldosterone receptor blockers in the treatment of hypertension
    Myron H Weinberger
    Indiana University School of Medicine, 541 Clinical Drive, Room 423, Indianapolis, IN 46202, USA
    J Clin Hypertens (Greenwich) 6:632-5. 2004
    ..This review will highlight the major findings from these studies...
  7. ncbi Is salt sensitivity of blood pressure linked to the cardiometabolic syndrome?
    Myron H Weinberger
    Department of Medicine Hypertension, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Cardiometab Syndr 1:217-9. 2006
  8. ncbi Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases
    M H Weinberger
    Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA
    Kidney Int 70:2051-3. 2006
    ..Adding aldosterone receptor blockers to these other agents may further halt the progression of CKD...
  9. ncbi Is primary aldosteronism a benign disorder? Old evidence reconfirmed
    Myron H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Am J Hypertens 19:628. 2006
  10. ncbi Pathogenesis of salt sensitivity of blood pressure
    Myron H Weinberger
    Indiana University Medical Center, 541 Clinical Drive, Room 423, Indianapolis, IN 46202, USA
    Curr Hypertens Rep 8:166-70. 2006
    ....
  11. ncbi Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
    Myron H Weinberger
    Indiana University School of Medicine, Hypertension Research Center, Indianapolis 46202 5111, USA
    Am J Hypertens 15:709-16. 2002
    ..Eplerenone, a selective aldosterone blocker (SAB) that is highly specific for the aldosterone receptor, has the potential to be efficacious in the treatment of hypertension...
  12. ncbi The influence of blood pressure and carbohydrate tolerance on vascular compliance in humans
    Myron H Weinberger
    Department of Medicine, Indiana University School of Medicine, Indianapolis, USA
    Am J Hypertens 15:678-82. 2002
    ..These findings have important implications for the preclinical detection and potential prevention of hypertension, diabetes, and associated vascular disease...
  13. ncbi Salt sensitivity is associated with an increased mortality in both normal and hypertensive humans
    Myron H Weinberger
    Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA
    J Clin Hypertens (Greenwich) 4:274-6. 2002
    ..Only initially normotensive, salt-resistant individuals had improved survival. Studies are continuing in order to elucidate the mechanisms by which salt sensitivity, even in normotensive subjects, may lead to reduced survival...
  14. ncbi Effects of age, race, gender, blood pressure, and estrogen on arterial compliance
    Myron H Weinberger
    Department of Medicine, Hypertension Research Center, Indiana University School of Medicine, Indianapolis, USA
    Am J Hypertens 15:358-63. 2002
    ..Although a variety of factors have been shown to influence vascular compliance in humans, few studies have been large enough to adequately assess the effects of age, race, gender, blood pressure (BP), and estrogen therapy...
  15. ncbi Salt sensitivity, pulse pressure, and death in normal and hypertensive humans
    M H Weinberger
    Indiana University School of Medicine, The Regenstrief Institute for Health Care, Roudebush Veteran s Administration Medical Center, Indianapolis, Indiana, USA
    Hypertension 37:429-32. 2001
    ..001). These observations provide unique evidence of a relationship between salt sensitivity and mortality that is independent of elevated blood pressure...
  16. ncbi Salt and blood pressure
    M H Weinberger
    Hypertension Research Center, Indianapolis, Indiana 46202 5111, USA
    Curr Opin Cardiol 15:254-7. 2000
    ..New observations related to the demographics, physiology, and mechanisms for these varied responses are also presented...
  17. doi Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy
    M H Weinberger
    Department of Medicine, Hypertension Research Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Hum Hypertens 24:823-30. 2010
    ..These results support the use of Val/HCTZ combination as initial therapy in hypertensive patients unlikely to achieve BP control with a single agent...
  18. doi Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome
    Myron H Weinberger
    Indiana University Medical Center, Indianapolis, IN, USA
    J Am Soc Hypertens 5:489-97. 2011
    ..4 mm Hg vs. -28.5 mm Hg; P < .001). Both treatments were well tolerated. Aliskiren/amlodipine 300/10 mg is more effective than amlodipine 10 mg in African Americans with stage 2 hypertension and obesity or MetS...
  19. ncbi The blood pressure effects of calcium supplementation in humans of known sodium responsiveness
    M H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis
    Am J Hypertens 6:799-805. 1993
    ..abstract truncated at 250 words)..
  20. ncbi Salt sensitivity and the blood pressure response to verapamil
    M H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis 46202-5111
    Am J Hypertens 7:515-9. 1994
    ..In this study verapamil lowered blood pressure in all subjects. We conclude that calcium channel blockade reduces blood pressure in essential hypertensive subjects during a normal sodium intake, independent of salt-sensitivity status...
  21. ncbi A comparison of two tests for the assessment of blood pressure responses to sodium
    M H Weinberger
    Department of Medicine, Indiana University School of Medicine, Indianapolis 46202-5111
    Am J Hypertens 6:179-84. 1993
    ..These findings demonstrate the congruity of two different approaches for the assessment of salt responsivity of blood pressure in humans.(ABSTRACT TRUNCATED AT 250 WORDS)..
  22. ncbi Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives
    M R Weir
    Department of Medicine, University of Maryland School of Medicine, Baltimore, USA
    Hypertension 31:1088-96. 1998
    ..These data demonstrate that controlling for salt sensitivity diminishes race-related differences in antihypertensive activity...
  23. ncbi Association between the CYP3A5 genotype and blood pressure
    Herbert Ho
    Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, 1001 W Tenth St, WD Myers Room W7123, Indianapolis, IN 46202, USA
    Hypertension 45:294-8. 2005
    ..We conclude that although untreated blood pressure may be higher in blacks with the CYP3A5*3/*3 genotype, the CYP3A5*1 allele may be associated with hypertension that is more refractory to treatment in this ethnic group...
  24. ncbi Salt sensitivity as a predictor of hypertension
    M H Weinberger
    Hypertension Research Center, Indiana University School of Medicine, Indianapolis 46202-5111
    Am J Hypertens 4:615S-616S. 1991
    ..A variety of associated markers of salt sensitivity has been described. Recent studies also link calcium and salt sensitivity of blood pressure...
  25. ncbi Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against
    Myron H Weinberger
    Hypertension Research Center, Indiana University Medical Center, Indianapolis, IN, USA
    J Clin Hypertens (Greenwich) 7:36-7; quiz 38-9. 2005
  26. ncbi Effects of oral calcium, potassium, digoxin, and nifedipine on natriuresis in normal humans
    F C Luft
    Department of Medicine, Indiana University School of Medicine, Indianapolis
    Am J Hypertens 2:14-9. 1989
    ..Nifedipine may also uncouple renin from aldosterone. Oral calcium supplementation and sodium-potassium dependent ATPase inhibition did not facilitate natriuresis...
  27. ncbi John Arthur Luetscher, Jr (1903-2005)
    Myron H Weinberger
    Department of Medicine, Indiana University Medical Center, Indianapolis, IN, USA
    Hypertension 47:627-8. 2006
  28. ncbi Estrogens, salt, blood pressure, and cardiovascular disease in women: how do we interpret the data?
    Myron H Weinberger
    Hypertension 47:1049-50. 2006
  29. ncbi Salt restriction in the treatment of isolated systolic and combined hypertension: is that enough?
    Myron H Weinberger
    Hypertension 46:31-2. 2005
  30. ncbi The cold pressor test: a new predictor of future hypertension?
    Myron H Weinberger
    Arch Intern Med 168:1732. 2008
  31. ncbi Are children doomed by what they eat and drink?
    Myron H Weinberger
    Hypertension 51:615-6. 2008
  32. doi Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial
    Karl Andersen
    Department of Medicine, Division of Cardiology, Landspitali University Hospital, Reykjavik, Iceland
    J Hypertens 26:589-99. 2008
    ....
  33. ncbi Ethnic differences in urine concentration: possible relationship to blood pressure
    Lise Bankir
    INSERM Unité 652, 17 Rue du Fer a Moulin, 75005 Paris, France
    Clin J Am Soc Nephrol 2:304-12. 2007
    ..If these results are confirmed in further studies, then vasopressin V2 receptor antagonists might offer a novel antihypertensive strategy, especially in the black population...
  34. ncbi Long renal arteries: too much of a good thing?
    Myron H Weinberger
    Hypertension 46:269-70. 2005
  35. ncbi More novel effects of diet on blood pressure and lipids
    Myron H Weinberger
    JAMA 294:2497-8. 2005